Pneumonia Risk and Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers

BACKGROUND: Recent studies have shown that use of angiotensin-converting enzyme (ACE) inhibitors may decrease pneumonia risk in various populations. We investigated the effect of ACE inhibitors and angiotensin II receptor blockers (ARBs) on pneumonia hospitalization in the general population of Taiw...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chia-Lin, Shau, Wen-Yi, Chang, Chia-Hsuin, Wu, Chi-Shin, Lai, Mei-Shu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Epidemiological Association 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775528/
https://www.ncbi.nlm.nih.gov/pubmed/23912052
http://dx.doi.org/10.2188/jea.JE20120112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775528/
https://www.ncbi.nlm.nih.gov/pubmed/23912052
http://dx.doi.org/10.2188/jea.JE20120112

Ejemplares similares